Literature DB >> 8762275

[Community-acquired pneumonia in children: importance of Mycoplasma pneumoniae infections and efficacy of antibiotics].

D Gendrel1, J Raymond, F Moulin, J L Iniguez, M Truong, S Ravilly, M Chaussain, P Lebon, G Kalifa.   

Abstract

OBJECTIVES: Define a therapeutic management schema adapted to children with community-acquired pneumonia.
METHODS: A prospective survey was conducted in 104 children over 18 months of age with community-acquired pneumonia. The pathogen was isolated in 85% of the cases.
RESULTS: Viral infection alone was proven in 30 children (respiratory syncytial virus in 10). Pneumococci pneumonia was found in 12 patients; the isolated strains were sensitive to penicillin. Apyrexia was obtained in 11/12 cases with amoxicillin. Mycoplasma infections occurred in 42% of the cases (41 alone and in association with pneumococci in 2 cases). Pneumococci and mycoplasma infections could not be differentiated with standard radiography and laboratory tests. Initial treatment with beta lactamines was always unsuccessful in children with mycoplasma infections. Apyrexia was achieved when antibiotics were changed to macrolides.
CONCLUSION: Since lower respiratory tract infections due to pneumococci are much more severe than those due to mycoplasma, beta lactamines should be given as first intention treatment for children over 18 months with pneumonia. Macrolides should be given in case of failure because mycoplasma would then be the most probable infectious agent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762275

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

Review 1.  [Epidemiology of community-acquired pneumonia in children. Current data].

Authors:  C Marguet; N Bocquel; E Mallet
Journal:  Arch Pediatr       Date:  1998       Impact factor: 1.180

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.